跳至主要内容
临床试验/CTRI/2025/01/079764
CTRI/2025/01/079764已完成2/3 期

Role of Individualized homoeopathic medicines in the management of Dermatophytosis assessed by Total symptoms score

DR YAMINIBEN PRAVINBHAI PATEL1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年2月10日最近更新:

试验速览

阶段
2/3 期
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
TOTAL SYMPTOMS SCORE TO ASSESS REDUCTION IN DERMATOPHYTOSIS SYMPTOMS

研究概览

简要总结

THIS STUDY IS PROSPECTIVE STUDY PRE TEST  POST TEST ONE GROUP EXPERIMENTAL STUDY TO ASSESS THE ROLE OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES FOR 8 MONTHS IN 100 PARTICIPANTS WITH DERMATOPHYTOSIS THAT WILL BE CONDUCTED AS PER INCLUSION AND EXCLUSION CRITERIA FROM OUTPATIENT DEPARTMENT AND THE OUTCOME MEASURES WILL ASSESS BY TOTAL SYMPTOMS SCORE OF THE PATIENTS FOLLOW UP AS PER NEED OF CASE UP TO 8 MONTHS OF DURATION

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)

入选标准

  • Age group Participant aged 20 TO 60 years Gender Male and female Patient will be selected on the basis of ICD 11 code of dermatophytosis 1F28 Patient who gave voluntary consent to be include in the study.

排除标准

  • Cases of ringworm complicated with other skin complaint like Psoriasis Eczema Candidial infection Atopic dermatitis Cases of ringworm in immuno compromised patient like AIDS HIV and who are taking immunosuppressive therapy or corticosteroid Cases with other systemic illness like uncontrolled Diabetes mellitus Patient who are taking any other medication such as oinments external application Allopathic Homoeopathic Ayurvedic etc for dermatophytosis.

结局指标

主要结局

TOTAL SYMPTOMS SCORE TO ASSESS REDUCTION IN DERMATOPHYTOSIS SYMPTOMS

时间窗: TOTAL SYMPTOMS SCORE WILL BE ASSESSED AT THE BASELINE AND AT THE END OF TREATMENT UPTO 8 MONTHS

次要结局

未报告次要终点

研究者

发起方
DR YAMINIBEN PRAVINBHAI PATEL
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR YAMINIBEN PRAVINBHAI PATEL

SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE

研究点 (1)

Loading locations...

相似试验